Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Fact Sheet   (TORR)


Potential 33x Opportunity: 3 Next-Generation Defence Stocks


Here is the latest financial fact sheet of TORRENT PHARMA. For more details, see the TORRENT PHARMA quarterly results and TORRENT PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

TORRENT PHARMA Price History

Price Rs 1,580.0
Mkt Cap Rs m 534,727
Vol '000 3.3
P/E X 66.8
P/CF X 37.2
EPS (TTM) Rs 23.7
1 Day % 2.6
No. of shares m 338.45
1 Week % 1.2
1 Month % 6.6
1 Year % 8.9
52 week H/L Rs 1,652.2/1,242.5
As on Aug 16, 2022 11:58:00 AM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TORRENT PHARMA Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
TORRENT PHARMA EQUITY SHARE DATA
High Rs1,5501,9642,2863,0403,304 
Low Rs1,1441,2451,4531,9332,478 
Sales per share (Unadj.) Rs351.6453.4469.2473.0502.8 
Earnings per share (Unadj.) Rs40.125.860.674.045.9 
Diluted earnings per shareRs20.012.930.337.023.0 
Cash flow per share (Unadj.) Rs64.262.399.2112.985.1 
Dividends per share (Unadj.) Rs14.0017.0032.0035.0048.00 
Adj. dividends per shareRs7.008.5016.0017.5024.00 
Avg Dividend yield %1.01.11.71.41.7 
Book value per share (Unadj.) Rs273.1279.2285.0344.9351.8 
Adj. book value per shareRs136.6139.6142.5172.5175.9 
Shares outstanding (eoy) m169.22169.22169.22169.22169.22 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x3.83.54.05.35.8 
Avg P/E ratio x33.662.230.933.662.9 
P/CF ratio (eoy) x21.025.818.822.034.0 
Price / Book Value ratio x4.95.76.67.28.2 
Dividend payout %34.965.952.847.3104.5 
Avg Mkt Cap Rs m227,901271,518316,358420,798489,231 
No. of employees `000NANANANANA 
Total wages/salary Rs m11,35314,03814,29014,39615,265 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
TORRENT PHARMA INCOME DATA
Net Sales Rs m59,49876,72879,39380,04685,080 
Other income Rs m3,0706361,2135691,966 
Total revenues Rs m62,56977,36480,60680,61587,046 
Gross profit Rs m13,41116,19521,70424,80119,466 
Depreciation Rs m4,0866,1776,5446,5786,622 
Interest Rs m3,0855,0384,5073,5292,551 
Profit before tax Rs m9,3105,61711,86615,26312,259 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2,5291,2541,6192,7444,487 
Profit after tax Rs m6,7814,36310,24712,5197,772 
Gross profit margin %22.521.127.331.022.9 
Effective tax rate %27.222.313.618.036.6 
Net profit margin %11.45.712.915.69.1 
TORRENT PHARMA BALANCE SHEET DATA
Current assets Rs m52,62450,37549,80955,23252,947 
Current liabilities Rs m52,02251,65354,54248,91644,151 
Net working cap to sales %1.0-1.7-6.07.910.3 
Current ratio x1.01.00.91.11.2 
Inventory Days Days4333161419 
Debtors Days Days87877 
Net fixed assets Rs m87,04987,13585,95681,29873,115 
Share capital Rs m846846846846846 
"Free" reserves Rs m45,37646,39747,38657,52658,683 
Net worth Rs m46,22247,24448,23258,37259,530 
Long term debt Rs m41,11539,12933,03929,41121,232 
Total assets Rs m139,673137,511135,765136,530126,062 
Interest coverage x4.02.13.65.35.8 
Debt to equity ratio x0.90.80.70.50.4 
Sales to assets ratio x0.40.60.60.60.7 
Return on assets %7.16.810.911.88.2 
Return on equity %14.79.221.221.413.1 
Return on capital %14.212.320.121.418.3 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m14,58022,10320,79321,53918,419 
Fx outflow Rs m3,6005,5226,0657,1363,337 
Net fx Rs m10,98016,58114,72714,40315,082 
TORRENT PHARMA CASH FLOW
From Operations Rs m 8,942 17,981 13,929 20,054 18,030 
From Investments Rs m -47,070 -2,413 1,986 -4,494 -1,966 
From Financial Activity Rs m 34,174 -13,145 -15,490 -16,508 -17,811 
Net Cashflow Rs m -3,655 2,380 731 -893 -1,742 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 71.3%
Institution 20.8%
Non-Institution 8.0%
Total 100.0%
Free Float 28.8%
Pledged promoter holdings 0.0%
Shareholding as on Jun 2022
 

Company Information

Regd Off Torrent House, Off Ashram Road, Ahmedabad - 380009
E-mail investorservices@torrentpharma.com Web www.torrentpharma.com
Tel 079-26599000 Fax 079-26582100
Sector PHARMACEUTICALS Group Torrent Group
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor Deloitte Haskins & Sells
CHM: Samir Mehta COMP SEC: Chintan Trivedi YEAR OF INC: 1972 BSE CODE: 500420 FV (Rs): 5 DIV YIELD (%): 1.5

Read: TORRENT PHARMA 2021-22 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    CIPLA    DR. REDDYS LAB    

Compare TORRENT PHARMA With:   LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    CIPLA    DR. REDDYS LAB    




Today's Market

Sensex Zooms 450 Points, Nifty Tops 17,800; FMCG and Realty Stocks Rally(10:30 am)

Asian share markets opened higher today as another round of weak US data provided a little hope that the Federal Reserve will temper its pace of interest rate hikes.